Carilion Clinic is leading coronavirus research right here, right now.
A new study is focusing on our community—and you can help.
With CARES Act funding from the Virginia Department of Health, we are surveying people in southwest Virginia to better understand the number of people who have COVID-19 in our region as well as a better understanding of activities that contribute to the spread of the virus here.
"Since the pandemic began in early March, we have learned a tremendous amount about COVID-19," said Paul Skolnik, M.D., chair of Carilion's Department of Medicine. "This study will allow us to determine the direct effect of the virus in our area."
Carilion Clinic has led and participated in research on the virus since it arrived in our region, incuding a statewide seroprevalence study led by the Commonwealth of Virginia last summer.
The study, however—the first dedicated seroprevalence study in southwest Virginia—will measure SARS-CoV-2 antibodies in participants who live in our service area.
Participation consists of taking a 10-minute online survey and having 5 milliliters of blood drawn at Quest Diagnostics or any of Carilion's hospitals.
"In additional to public enrollment, we're recruiting participants from Carilion Clinic electronic medical records and the general public with the help of Virginia Tech's Department of Population Health," said Anthony Baffoe-Bonnie, M.D., director of Infection Prevention and Control at Carilion.
If you have questions not addressed at the survey link, you may email the research team at firstname.lastname@example.org.